abstract |
The present invention relates to a compound represented bynthe general formula [I]:n nwherein Ar 1 represents an aryl group which may have a substituentnselected from the group consisting of a halogen atom and lower alkylnand lower haloalkyl groups; Ar 2 represents an aryl or heteroaryl groupnwhich may have a substituent selected from the group consisting ofna halogen atom and lower alkyl, lower alkenyl, lower haloalkyl, lowernalkoxy, lower alkylthio, lower alkylamino, lower dialkylamino andnaryl groups; R 1 and R 2 may be the same or different and each representsna hydrogen atom or a lower alkyl group; R 3 and R 4 may be the same orndifferent and each represents a hydrogen atom or a lower alkyl group,nor R 3 and R 4 are linked to each other to form an alkylene groupncontaining 2 to 4 carbon atoms which may have a lower alkyl group;nand R 5 represents a hydrogen atom or a lower alkyl or lower alkoxyngroup, nor its salt, a method for its preparation as well as an agent fornthe treatment of bulimia, obesity or diabetes comprising it as annactive ingredient. |